Ex Parte PEOPLES et al - Page 19


              Appeal No. 2005-1383                                                                                       
              Application No. 09/364,847                                                                                 

                     First, we point out that claims 5 and 6 are in a product-by-process format.  The                    
              appellants are advised that an invention defined in this manner is a product and not a                     
              process.  In re Thorpe, 777 F.2d 695, 697, 227 USPQ 964, 966 (Fed. Cir. 1985).  Thus,                      
              it is the patentability of the product which must be considered.  In the case before us,                   
              we do not find, and the appellants have not pointed out, any characteristics which                         
              distinguish the protein fusion recited in claims 5 and 6 from that which is recited in claim               
              1.  That is, the fusion protein of claim 1 does not automatically change when it is                        
              expressed in a plant cell or in bacteria.  Thus, the reasons for our finding the fusion                    
              protein of claim 1 unpatentable over the teachings of Peoples and Bülow apply with                         
              equal force to claims 5 and 6 because they are directed to the same composition.                           
                     Second, even if we assume arguendo, that claims 5 and 6 are directed to a                           
              method of expressing the fusion protein in a plant cell or a bacterium, we would find the                  
              appellants’ argument unconvincing.  We point out that Bülow discloses the expression                       
              of the recombinant bifunctional enzymes in bacteria (E. coli).  More importantly, both the                 
              specification (p. 1, lines 13-14) and Peoples discloses that PHA is naturally produced in                  
              bacteria (e.g., col. 2, lines 50-52).  Peoples further discloses the isolation and                         
              expression of numerous genes which encode catalytically active enzymes involved in                         
              the PHA biosynthetic pathway in bacteria (e.g., col. 3, lines 38-41, lines 50-64; col. 12,                 
              lines 19-51; col. 14, lines 20-33; col. 16, lines 16-56; col. 19, lines 23-60; Tables 2 and                
              3).  Peoples still further discloses that the genes encoding the thiolase, reductase                       
              and/or polymerase for PHA can be expressed in plants to produce the desired product                        
              (e.g., col. 3, lines 38-41, lines 44-49 and lines 63-66; col. 26, lines 42-46).  Thus,                     
              assuming arguendo that claims 5 and 6 were directed to the expression of the protein                       



                                                           19                                                            

Page:  Previous  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  Next 

Last modified: November 3, 2007